Invent Medic Sweden AbNGM: IMS

IMS: Efemia sales up 40% in H1 2024, narrowing losses but more capital needed for growth

· Issued by Invent Medic Sweden AB

Efemia Bladder Support sales surged over 40% in H1 2024, offsetting FlowCup's e-commerce decline. Losses narrowed year-over-year, but additional capital is needed before reaching cash flow positivity.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis